SEARCH

SEARCH BY CITATION

References

  • Ayello, J., van de Ven, C., Fortino, W., Wade-Harris, C., Satwani, P., Baxi, L., Simpson, L.L., Sanger, W., Pickering, D., Kurtzberg, J. & Cairo, M.S. (2006) Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 12, 608622.
  • Ball, L.M., Lankester, A.C., Bredius, R.G., Fibbe, W.E., van Tol, M.J. & Egeler, R.M. (2005) Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplantation, 35(Suppl. 1), S35S38.
  • Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., Locatelli, F. & Fibbe, W.E. (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110, 27642767.
  • Bhatia, M., Militano, O., Jin, Z., Figurski, M., Shaw, L., Moore, V., Morris, E., Tallamy, B., van deVen, C., Ayello, J., Baxter-Lowe, L., Satwani, P., George, D., Bradley, M.B., Garvin, J. & Cairo, M.S. (2010) An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 16, 333343.
  • Bunin, N., Aplenc, R., Grupp, S., Pierson, G. & Monos, D. (2006) Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias. Bone Marrow Transplantation, 37, 143149.
  • Cairo, M.S., Rocha, V., Gluckman, E., Hale, G. & Wagner, J. (2008) Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 14, 4453.
  • Chakraverty, R., Orti, G., Roughton, M., Shen, J., Fielding, A., Kottaridis, P., Milligan, D., Collin, M., Crawley, C., Johnson, P., Clark, A., Parker, A., Bloor, A., Pettengell, R., Snowden, J., Pettitt, A., Clark, R., Hale, G., Peggs, K., Thomson, K., Morris, E. & Mackinnon, S. (2010) Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. Blood, 116, 30803088.
  • Chen, X., Hale, G.A., Barfield, R., Benaim, E., Leung, W.H., Knowles, J., Horwitz, E.M., Woodard, P., Kasow, K., Yusuf, U., Behm, F.G., Hayden, R.T., Shurtleff, S.A., Turner, V., Srivastava, D.K. & Handgretinger, R. (2006) Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. British Journal Haematology, 135, 524532.
  • Craddock, C., Nagra, S., Peniket, A., Brookes, C., Buckley, L., Nikolousis, E., Duncan, N., Tauro, S., Yin, J., Liakopoulou, E., Kottaridis, P., Snowden, J., Milligan, D., Cook, G., Tholouli, E., Littlewood, T., Peggs, K., Vyas, P., Clark, F., Cook, M., Mackinnon, S. & Russell, N. (2010) Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica, 95, 989995.
  • Devine, S.M., Carter, S., Soiffer, R.J., Pasquini, M.C., Hari, P.N., Stein, A., Lazarus, H.M., Linker, C., Stadtmauer, E.A., Alyea, III, E.P., Keever-Taylor, C.A. & O'Reilly, R.J. (2011) Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 17, 13431351.
  • Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R.I., Cecchini, D., Aloisi, T., Perruccio, K., Ruggeri, L., Balucani, C., Pierini, A., Sportoletti, P., Aristei, C., Falini, B., Reisner, Y., Velardi, A., Aversa, F. & Martelli, M.F. (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood, 117, 39213928.
  • van Esser, J.W., van der Holt, B., Meijer, E., Niesters, H.G., Trenschel, R., Thijsen, S.F., van Loon, A.M., Frassoni, F., Bacigalupo, A., Schaefer, U.W., Osterhaus, A.D., Gratama, J.W., Lowenberg, B., Verdonck, L.F. & Cornelissen, J.J. (2001) Epstein–Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT. Blood, 98, 972978.
  • Eyrich, M., Lang, P., Lal, S., Bader, P., Handgretinger, R., Klingebiel, T., Niethammer, D. & Schlegel, P.G. (2001) A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors. British Journal of Haematology, 114, 422432.
  • Feuchtinger, T., Richard, C., Pfeiffer, M., Neuhauser, F., Lucke, J., Handgretinger, R., Greil, J., Bader, P., Klingebiel, T., Schlegel, P.G., Jahn, G., Niethammer, D. & Lang, P. (2005) Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klinische Padiatrie, 217, 339344.
  • Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. & Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 134, 6476.
  • Firat, H., Giarratana, M.C., Kobari, L., Poloni, A., Bouchet, S., Labopin, M., Gorin, N.C. & Douay, L. (1998) Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques. Bone Marrow Transplantation, 21, 933938.
  • Flomenberg, N., Baxter-Lowe, L.A., Confer, D., Fernandez-Vina, M., Filipovich, A., Horowitz, M., Hurley, C., Kollman, C., Anasetti, C., Noreen, H., Begovich, A., Hildebrand, W., Petersdorf, E., Schmeckpeper, B., Setterholm, M., Trachtenberg, E., Williams, T., Yunis, E. & Weisdorf, D. (2004) Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood, 104, 19231930.
  • Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295304.
  • Handgretinger, R., Klingebiel, T., Lang, P., Schumm, M., Neu, S., Geiselhart, A., Bader, P., Schlegel, P.G., Greil, J., Stachel, D., Herzog, R.J. & Niethammer, D. (2001) Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplantation, 27, 777783.
  • Handgretinger, R., Chen, X., Pfeiffer, M., Mueller, I., Feuchtinger, T., Hale, G.A. & Lang, P. (2007) Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Annals of the New York Academy of Sciences, 1106, 279289.
  • Ho, V.T. & Soiffer, R.J. (2001) The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood, 98, 31923204.
  • Horn, B., Soni, S., Khan, S., Petrovic, A., Breslin, N., Cowan, M., Pelle-Day, G., Cooperstein, E. & Baxter-Lowe, L.A. (2009) Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies. Bone Marrow Transplantation, 43, 469476.
  • Jakubowski, A.A., Small, T.N., Kernan, N.A., Castro-Malaspina, H., Collins, N., Koehne, G., Hsu, K.C., Perales, M.A., Papanicolaou, G., van den Brink, M.R., O'Reilly, R.J., Young, J.W. & Papadopoulos, E.B. (2011) T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 17, 13351342.
  • Kalwak, K., Porwolik, J., Mielcarek, M., Gorczynska, E., Owoc-Lempach, J., Ussowicz, M., Dyla, A., Musial, J., Pazdzior, D., Turkiewicz, D. & Chybicka, A. (2010) Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 16, 13881401.
  • Kaplan, E.L. & Meier, P. (1958) Nonparametric-estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Kennedy-Nasser, A.A., Leung, K.S., Martinez, C.A., Bollard, C.M., Gottschalk, S., Craddock, J.A., Ahmed, N., Heslop, H.E., Brenner, M.K. & Krance, R.A. (2011) Haploidentical stem cell transplants in children with acute lymphoblastic leukemia in first or second remission. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 17, S310S311.
  • Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., McCullough, J., McClave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine, 328, 593602.
  • Klingebiel, T., Cornish, J., Labopin, M., Locatelli, F., Balduzzi, A., Owoc, J., Fagioli, F., Engelhard, D., Peters, C., Dini, G. & Rocha, V. (2006) Risk factors for outcome after haploidentical hematopoietic stem cell transplant in children with very high risk acute lymphoblastic leukemia: impact of centre experience. A survey on behalf of the ALWP and PDWP of the EBMT. ASH Annual Meeting Abstracts, 108, 438.
  • Kremens, B., Basu, O., Peceny, R., Grosse-Wilde, H., Schaefer, U.W. & Havers, W. (2002) Allogeneic CD34+ -selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases. Bone Marrow Transplantation, 29, 913.
  • Landgren, O., Gilbert, E.S., Rizzo, J.D., Socie, G., Banks, P.M., Sobocinski, K.A., Horowitz, M.M., Jaffe, E.S., Kingma, D.W., Travis, L.B., Flowers, M.E., Martin, P.J., Deeg, H.J. & Curtis, R.E. (2009) Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood, 113, 49925001.
  • Lang, P. & Handgretinger, R. (2008) Haploidentical SCT in children: an update and future perspectives. Bone Marrow Transplantation, 42(Suppl 2), S54S59.
  • Lang, P., Handgretinger, R., Niethammer, D., Schlegel, P.G., Schumm, M., Greil, J., Bader, P., Engel, C., Scheel-Walter, H., Eyrich, M. & Klingebiel, T. (2003) Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood, 101, 16301636.
  • Lang, P., Greil, J., Bader, P., Handgretinger, R., Klingebiel, T., Schumm, M., Schlegel, P.G., Feuchtinger, T., Pfeiffer, M., Scheel-Walter, H., Fuhrer, M., Martin, D. & Niethammer, D. (2004a) Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells, Molecules, and Diseases, 33, 281287.
  • Lang, P., Klingebiel, T., Bader, P., Greil, J., Schumm, M., Schlegel, P.G., Eyrich, M., Mueller-Weihrich, S., Niethammer, D. & Handgretinger, R. (2004b) Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplantation, 33, 2532.
  • Lee, S.J., Vogelsang, G. & Flowers, M.E. (2003) Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 9, 215233.
  • Leen, A.M., Myers, G.D., Sili, U., Huls, M.H., Weiss, H., Leung, K.S., Carrum, G., Krance, R.A., Chang, C.C., Molldrem, J.J., Gee, A.P., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2006) Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine, 12, 11601166.
  • Leen, A.M., Christin, A., Myers, G.D., Liu, H., Cruz, C.R., Hanley, P.J., Kennedy-Nasser, A.A., Leung, K.S., Gee, A.P., Krance, R.A., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2009) Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein–Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood, 114, 42834292.
  • Liao, Y., Geyer, M.B., Yang, A.J. & Cairo, M.S. (2011) Cord blood transplantation and stem cell regenerative potential. Experimental Hematology, 39, 393412.
  • Lockitch, G., Halstead, A., Quigley, G. & MacCallum, C. (1988) Age- and sex-specific pediatric reference intervals: study design and methods illustrated by measurement of serum proteins with the Behring LN Nephelometer. Clinical Chemistry, 34, 16181621.
  • Marks, D.I., Khattry, N., Cummins, M., Goulden, N., Green, A., Harvey, J., Hunt, L.P., Keen, L., Robinson, S.P., Steward, C.G. & Cornish, J.M. (2006) Haploidentical stem cell transplantation for children with acute leukaemia. British Journal of Haematology, 134, 196201.
  • Ortin, M., Raj, R., Kinning, E., Williams, M. & Darbyshire, P.J. (2002) Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. Bone Marrow Transplantation, 30, 359366.
  • Osterborg, A., Foa, R., Bezares, R.F., Dearden, C., Dyer, M.J., Geisler, C., Lin, T.S., Montillo, M., van Oers, M.H., Wendtner, C.M. & Rai, K.R. (2009) Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia. Leukemia, 23, 19801988.
  • Osunkwo, I., Bessmertny, O., Harrison, L., Cheung, Y.K., Van de Ven, C., del Toro, G., Garvin, J., George, D., Bradley, M.B., Wolownik, K., Wischhover, C., Levy, J., Skerrett, D. & Cairo, M.S. (2004) A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 10, 246258.
  • Peters, C., Matthes-Martin, S., Fritsch, G., Holter, W., Lion, T., Witt, V., Hocker, P., Fischer, G., Dieckmann, K., Handgretinger, R., Klingebiel, T. & Gadner, H. (1999) Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia, 13, 20702078.
  • Pulsipher, M.A., Boucher, K.M., Wall, D., Frangoul, H., Duval, M., Goyal, R.K., Shaw, P.J., Haight, A.E., Grimley, M., Grupp, S.A., Kletzel, M. & Kadota, R. (2009) Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood, 114, 14291436.
  • Remberger, M., Beelen, D.W., Fauser, A., Basara, N., Basu, O. & Ringden, O. (2005) Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors. Blood, 105, 548551.
  • Roman, E., Osunkwo, I., Militano, O., Cooney, E., van de Ven, C. & Cairo, M.S. (2008) Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Pediatric Blood & Cancer, 50, 325330.
  • Satwani, P., Harrison, L., Morris, E., Del Toro, G. & Cairo, M.S. (2005) Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 11, 403422.
  • Satwani, P., Morris, E., Bradley, M.B., Bhatia, M., van de Ven, C. & Cairo, M.S. (2008) Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases. Pediatric Blood & Cancer, 50, 18.
  • Satwani, P., Baldinger, L., Freedman, J., Jacobson, J.S., Guerra, J., van de Ven, C., Morris, E., Garvin, J., George, D., Bradley, M.B., Bhatia, M., Tallamy, B., Schwartz, J., Jin, Z. & Cairo, M.S. (2009) Incidence of viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 15, 15871595.
  • Sedlacek, P., Formankova, R., Keslova, P., Sramkova, L., Hubacek, P., Krol, L., Kulich, M. & Stary, J. (2006) Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin. Bone Marrow Transplantation, 38, 745750.
  • Shaw, P.J., Kan, F., Woo Ahn, K., Spellman, S.R., Aljurf, M., Ayas, M., Burke, M., Cairo, M.S., Chen, A.R., Davies, S.M., Frangoul, H., Gajewski, J., Gale, R.P., Godder, K., Hale, G.A., Heemskerk, M.B., Horan, J., Kamani, N., Kasow, K.A., Chan, K.W., Lee, S.J., Leung, W.H., Lewis, V.A., Miklos, D., Oudshoorn, M., Petersdorf, E.W., Ringden, O., Sanders, J., Schultz, K.R., Seber, A., Setterholm, M., Wall, D.A., Yu, L. & Pulsipher, M.A. (2010) Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood, 116, 40074015.
  • Shereck, E.B., Cooney, E., van de Ven, C., Della-Lotta, P. & Cairo, M.S. (2007) A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatric Blood & Cancer, 49, 306312.
  • Socie, G., Stone, J.V., Wingard, J.R., Weisdorf, D., Henslee-Downey, P.J., Bredeson, C., Cahn, J.Y., Passweg, J.R., Rowlings, P.A., Schouten, H.C., Kolb, H.J. & Klein, J.P. (1999) Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. New England Journal of Medicine, 341, 1421.
  • Stainer, C.J., Miflin, G., Anderson, S., Davy, B., McQuaker, I.G. & Russell, N.H. (1998) A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections. Journal of Hematotherapy, 7, 375383.
  • Urbano-Ispizua, A., Rozman, C., Pimentel, P., Solano, C., de la Rubia, J., Brunet, S., Perez-Oteiza, J., Ferra, C., Zuazu, J., Caballero, D., Carvalhais, A., Diez, J.L., Espigado, I., Martinez, C., Campilho, F., Sanz, M.A., Sierra, J., Garcia-Conde, J. & Montserrat, E. (2001) The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood, 97, 383387.
  • Wagner, J.E., Santos, G.W., Noga, S.J., Rowley, S.D., Davis, J., Vogelsang, G.B., Farmer, E.R., Zehnbauer, B.A., Saral, R. & Donnenberg, A.D. (1990) Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I–II clinical trial. Blood, 75, 13701377.
  • Wagner, J.E., Thompson, J.S., Carter, S.L. & Kernan, N.A. (2005) Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial. Lancet, 366, 733741.
  • Waxman, I.M., Militano, O., Baldinger, L., Roman, E., Qualter, E., Morris, E., Garvin, J., Bradley, M.B., Bhatia, M., Satwani, P., George, D., Del Toro, G., Hawks, R., Wolownik, K., Foley, S., Cheung, Y.K., Schwartz, J., van de Ven, C., Baxter-Lowe, L.A. & Cairo, M.S. (2009) Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. Pediatric Transplantation, 13, 464474.